Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_assertion type Assertion NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_head.
- NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_assertion description "[Collectively, these data suggest that PTPN22 overexpression represents a protective mechanism that allows autoantigen-activated CLL cells to escape from negative selection and indicate that this mechanism could be exploited for therapeutic purposes by targeting PTPN22 with PKC inhibitors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_provenance.
- NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_assertion evidence source_evidence_literature NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_provenance.
- NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_assertion SIO_000772 22569400 NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_provenance.
- NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_assertion wasDerivedFrom befree-2016 NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_provenance.
- NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_assertion wasGeneratedBy ECO_0000203 NP980582.RAaNdUDjF2S9hx-UC8v6h6yq5i1zc4A3W3mkraOZgd_Z8130_provenance.